Inhibitor Therapeutics, Inc. — Balance Sheet Charts
38 snapshots of history · ending 2022-09-30 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-31.8% -$29K
$63K
Current Assets↓-29.9% -$27K
$63K
Cash & Equivalents↓-0.4% -$229
$53K
Total Liabilities↑+12.6% +$458K
$4M
Current Liabilities↑+84.1% +$497K
$1M
Account Payables↑+7.1% +$22K
$326K
Stockholders Equity↓-13.8% -$488K
$-4M
Retained Earnings↓-0.8% -$488K
$-58M
Operating Lease ROU Asset
—
Operating Lease Liability
—
Gross PP&E
—
Accumulated Depreciation
—
Debt Due Y1
—
Total Debt Carrying Amount
—